$BCOW
1895 Bancorp of Wisconsin, Inc. /MD/

2023 Q3 Form 10-Q Financial Statement

#000095017023041457 Filed on August 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $5.371M $5.017M
YoY Change 24.47% 36.81%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $120.0K $120.0K
YoY Change -22.08% -23.08%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $2.419M $1.951M
YoY Change 507.79% 427.3%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$2.216M -$781.0K
YoY Change -1628.28% 108.82%
Income Tax $1.400M -$273.0K
% Of Pretax Income
Net Earnings -$3.641M -$508.0K
YoY Change -3036.29% 110.79%
Net Earnings / Revenue -67.79% -10.13%
Basic Earnings Per Share -$0.66 -$0.09
Diluted Earnings Per Share -$0.66 -$0.09
COMMON SHARES
Basic Shares Outstanding 6.155M 6.215M
Diluted Shares Outstanding 5.535M 5.545M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $29.89M $26.21M
YoY Change 62.22% 13.53%
Cash & Equivalents $26.60M $22.80M
Short-Term Investments $3.286M $3.416M
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $5.240M $5.308M
YoY Change -5.79% -6.63%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $554.6M $553.4M
YoY Change 4.77% 3.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.100M $700.0K
YoY Change 674.65% 446.88%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.100M $700.0K
YoY Change 79.45% 13.27%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $17.80M $15.90M
YoY Change 7.54% 17.39%
Total Long-Term Liabilities $17.80M $15.90M
YoY Change 7.54% 17.39%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.100M $700.0K
Total Long-Term Liabilities $17.80M $15.90M
Total Liabilities $484.4M $479.2M
YoY Change 6.84% 5.41%
SHAREHOLDERS EQUITY
Retained Earnings $36.18M $39.82M
YoY Change -12.71% -3.64%
Common Stock $62.00K $62.00K
YoY Change -1.59% -3.13%
Preferred Stock
YoY Change
Treasury Stock (at cost) $295.0K $295.0K
YoY Change -1.99% -1.99%
Treasury Stock Shares
Shareholders Equity $70.16M $74.13M
YoY Change
Total Liabilities & Shareholders Equity $554.6M $553.4M
YoY Change 4.77% 3.31%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$3.641M -$508.0K
YoY Change -3036.29% 110.79%
Depreciation, Depletion And Amortization $120.0K $120.0K
YoY Change -22.08% -23.08%
Cash From Operating Activities $520.0K $250.0K
YoY Change -57.41% -74.12%
INVESTING ACTIVITIES
Capital Expenditures $640.0K $30.00K
YoY Change -2164.52% -193.75%
Acquisitions
YoY Change
Other Investing Activities -$760.0K -$9.180M
YoY Change -61.09% -63.06%
Cash From Investing Activities -$1.400M -$9.210M
YoY Change -29.44% -62.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.690M 2.750M
YoY Change -224.87% -142.66%
NET CHANGE
Cash From Operating Activities 520.0K 250.0K
Cash From Investing Activities -1.400M -9.210M
Cash From Financing Activities 4.690M 2.750M
Net Change In Cash 3.810M -6.210M
YoY Change -184.31% -79.55%
FREE CASH FLOW
Cash From Operating Activities $520.0K $250.0K
Capital Expenditures $640.0K $30.00K
Free Cash Flow -$120.0K $220.0K
YoY Change -109.58% -77.96%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001847360
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201613Member
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40609
dei Entity Registrant Name
EntityRegistrantName
1895 Bancorp of Wisconsin, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
61-1993378
dei Entity Address Address Line1
EntityAddressAddressLine1
7001 West Edgerton Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
Greenfield
dei Entity Address State Or Province
EntityAddressStateOrProvince
WI
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
53220
dei City Area Code
CityAreaCode
414
dei Local Phone Number
LocalPhoneNumber
421-8200
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
BCOW
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6155077
CY2023Q2 us-gaap Cash And Due From Banks
CashAndDueFromBanks
18782000
CY2022Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
26029000
CY2023Q2 us-gaap Federal Funds Sold
FederalFundsSold
4013000
CY2022Q4 us-gaap Federal Funds Sold
FederalFundsSold
2315000
CY2023Q2 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
22795000
CY2022Q4 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
28344000
CY2023Q2 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
3416000
CY2022Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
2924000
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
107631000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
114492000
CY2022Q4 us-gaap Loans Receivable Held For Sale Amount
LoansReceivableHeldForSaleAmount
125000
CY2023Q2 bcow Deferred Costs Loans Net
DeferredCostsLoansNet
384159000
CY2022Q4 bcow Deferred Costs Loans Net
DeferredCostsLoansNet
362777000
CY2023Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
3643000
CY2022Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
3203000
CY2023Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
380516000
CY2022Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
359574000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5308000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5451000
CY2023Q2 bcow Mortgage Servicing Rights Net
MortgageServicingRightsNet
1777000
CY2022Q4 bcow Mortgage Servicing Rights Net
MortgageServicingRightsNet
1860000
CY2023Q2 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
4870000
CY2022Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
3429000
CY2023Q2 us-gaap Interest Receivable
InterestReceivable
1266000
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
1257000
CY2023Q2 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
13813000
CY2022Q4 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
14316000
CY2023Q2 us-gaap Other Assets
OtherAssets
11983000
CY2022Q4 us-gaap Other Assets
OtherAssets
11244000
CY2023Q2 us-gaap Assets
Assets
553375000
CY2022Q4 us-gaap Assets
Assets
543016000
CY2023Q2 us-gaap Deposits
Deposits
371190000
CY2022Q4 us-gaap Deposits
Deposits
387721000
CY2023Q2 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
8141000
CY2022Q4 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
1029000
CY2023Q2 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
91488000
CY2022Q4 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
71464000
CY2023Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
698000
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
291000
CY2023Q2 us-gaap Other Liabilities
OtherLiabilities
7732000
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
7149000
CY2023Q2 us-gaap Liabilities
Liabilities
479249000
CY2022Q4 us-gaap Liabilities
Liabilities
467654000
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6187587
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6236168
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6158069
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6206105
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
62000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
62000
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
49964000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
49931000
CY2023Q2 bcow Employee Stock Ownership Plan Esop Number Of Unallocated Shares
EmployeeStockOwnershipPlanEsopNumberOfUnallocatedShares
444010
CY2022Q4 bcow Employee Stock Ownership Plan Esop Number Of Unallocated Shares
EmployeeStockOwnershipPlanEsopNumberOfUnallocatedShares
453792
CY2023Q2 bcow Employee Stock Ownership Plan Esop Unallocated Compensation
EmployeeStockOwnershipPlanEsopUnallocatedCompensation
4214000
CY2022Q4 bcow Employee Stock Ownership Plan Esop Unallocated Compensation
EmployeeStockOwnershipPlanEsopUnallocatedCompensation
4307000
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
29518
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
30063
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
295000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
301000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
39816000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
41468000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-11207000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-11491000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
74126000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
75362000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
553375000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
543016000
CY2023Q2 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
4238000
CY2022Q2 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
3009000
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
8064000
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
6299000
CY2023Q2 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
588000
CY2022Q2 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
566000
us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
1191000
us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
1114000
CY2023Q2 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
191000
CY2022Q2 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
92000
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
476000
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
139000
CY2023Q2 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
5017000
CY2022Q2 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
3667000
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
9731000
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
7552000
CY2023Q2 us-gaap Interest Expense Deposits
InterestExpenseDeposits
1296000
CY2022Q2 us-gaap Interest Expense Deposits
InterestExpenseDeposits
187000
us-gaap Interest Expense Deposits
InterestExpenseDeposits
2278000
us-gaap Interest Expense Deposits
InterestExpenseDeposits
356000
CY2023Q2 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
654000
CY2022Q2 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
181000
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
1148000
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
350000
CY2023Q2 us-gaap Interest Expense Other
InterestExpenseOther
1000
CY2022Q2 us-gaap Interest Expense Other
InterestExpenseOther
2000
us-gaap Interest Expense Other
InterestExpenseOther
3000
us-gaap Interest Expense Other
InterestExpenseOther
4000
CY2023Q2 us-gaap Interest Expense
InterestExpense
1951000
CY2022Q2 us-gaap Interest Expense
InterestExpense
370000
us-gaap Interest Expense
InterestExpense
3429000
us-gaap Interest Expense
InterestExpense
710000
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
3066000
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
3297000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
6302000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
6842000
CY2023Q2 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
75000
CY2022Q2 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
105000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
150000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
210000
CY2023Q2 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
2991000
CY2022Q2 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
3192000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
6152000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
6632000
CY2023Q2 bcow Service Charges And Other Fees
ServiceChargesAndOtherFees
239000
CY2022Q2 bcow Service Charges And Other Fees
ServiceChargesAndOtherFees
257000
bcow Service Charges And Other Fees
ServiceChargesAndOtherFees
464000
bcow Service Charges And Other Fees
ServiceChargesAndOtherFees
493000
CY2023Q2 bcow Loan Servicing
LoanServicing
157000
CY2022Q2 bcow Loan Servicing
LoanServicing
171000
bcow Loan Servicing
LoanServicing
330000
bcow Loan Servicing
LoanServicing
348000
CY2023Q2 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
30000
CY2022Q2 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
106000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
68000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
184000
CY2023Q2 bcow Increase In Cash Surrender Value Of Life Insurance
IncreaseInCashSurrenderValueOfLifeInsurance
110000
CY2022Q2 bcow Increase In Cash Surrender Value Of Life Insurance
IncreaseInCashSurrenderValueOfLifeInsurance
105000
bcow Increase In Cash Surrender Value Of Life Insurance
IncreaseInCashSurrenderValueOfLifeInsurance
217000
bcow Increase In Cash Surrender Value Of Life Insurance
IncreaseInCashSurrenderValueOfLifeInsurance
209000
CY2023Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
225000
CY2022Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-522000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
444000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-733000
CY2023Q2 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
159000
CY2022Q2 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
1000
us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
165000
us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
7000
CY2023Q2 us-gaap Noninterest Income
NoninterestIncome
920000
CY2022Q2 us-gaap Noninterest Income
NoninterestIncome
118000
us-gaap Noninterest Income
NoninterestIncome
1688000
us-gaap Noninterest Income
NoninterestIncome
508000
CY2023Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
3060000
CY2022Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2034000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
5973000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
4318000
CY2023Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
21000
CY2022Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
99000
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
71000
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
113000
CY2023Q2 us-gaap Loan Processing Fee
LoanProcessingFee
222000
CY2022Q2 us-gaap Loan Processing Fee
LoanProcessingFee
209000
us-gaap Loan Processing Fee
LoanProcessingFee
446000
us-gaap Loan Processing Fee
LoanProcessingFee
410000
CY2023Q2 us-gaap Equipment Expense
EquipmentExpense
299000
CY2022Q2 us-gaap Equipment Expense
EquipmentExpense
330000
us-gaap Equipment Expense
EquipmentExpense
637000
us-gaap Equipment Expense
EquipmentExpense
684000
CY2023Q2 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
85000
CY2022Q2 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
36000
us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
121000
us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
62000
CY2023Q2 us-gaap Other Noninterest Expense
OtherNoninterestExpense
1005000
CY2022Q2 us-gaap Other Noninterest Expense
OtherNoninterestExpense
976000
us-gaap Other Noninterest Expense
OtherNoninterestExpense
1885000
us-gaap Other Noninterest Expense
OtherNoninterestExpense
2041000
CY2023Q2 us-gaap Noninterest Expense
NoninterestExpense
4692000
CY2022Q2 us-gaap Noninterest Expense
NoninterestExpense
3684000
us-gaap Noninterest Expense
NoninterestExpense
9133000
us-gaap Noninterest Expense
NoninterestExpense
7628000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-781000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-374000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1293000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-488000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-273000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-133000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-424000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-192000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-508000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-241000
us-gaap Net Income Loss
NetIncomeLoss
-869000
us-gaap Net Income Loss
NetIncomeLoss
-296000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5545335
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5843104
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5548562
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5858449
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5545335
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5843104
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5548562
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5858449
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-508000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-241000
us-gaap Net Income Loss
NetIncomeLoss
-869000
us-gaap Net Income Loss
NetIncomeLoss
-296000
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-1841000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-4791000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
388000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-11934000
CY2023Q2 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-1841000
CY2022Q2 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-4791000
us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
388000
us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-11934000
CY2023Q2 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-497000
CY2022Q2 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-1294000
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
104000
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-3222000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1344000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3497000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
284000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-8712000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1852000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3738000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-585000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9008000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
85202000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-241000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3497000
CY2022Q2 us-gaap Employee Stock Ownership Plan Esop Shares Contributed To Esop
EmployeeStockOwnershipPlanESOPSharesContributedToESOP
50757
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
545000
CY2022Q2 bcow Employee Stock Ownership Plan Esop Number Of Committed To Be Released Shares During Period
EmployeeStockOwnershipPlanEsopNumberOfCommittedToBeReleasedSharesDuringPeriod
9865
CY2022Q2 bcow Employee Stock Ownership Plan Value Committed To Be Released
EmployeeStockOwnershipPlanValueCommittedToBeReleased
51000
CY2022Q2 bcow Adjustments To Additional Paid In Capital Purchase And Retirement Of Common Stock
AdjustmentsToAdditionalPaidInCapitalPurchaseAndRetirementOfCommonStock
-64000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
60000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
80966000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
75939000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-508000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1344000
CY2023Q2 bcow Employee Stock Ownership Plan Esop Number Of Committed To Be Released Shares During Period
EmployeeStockOwnershipPlanEsopNumberOfCommittedToBeReleasedSharesDuringPeriod
4918
CY2023Q2 bcow Employee Stock Ownership Plan Value Committed To Be Released
EmployeeStockOwnershipPlanValueCommittedToBeReleased
30000
CY2023Q2 bcow Adjustments To Additional Paid In Capital Repurchase And Cancellation Of Common Stock Stock Repurchase Program Shares
AdjustmentsToAdditionalPaidInCapitalRepurchaseAndCancellationOfCommonStockStockRepurchaseProgramShares
14400
CY2023Q2 bcow Adjustments To Additional Paid In Capital Repurchase And Cancellation Of Common Stock Stock Repurchase Program Value
AdjustmentsToAdditionalPaidInCapitalRepurchaseAndCancellationOfCommonStockStockRepurchaseProgramValue
-103000
CY2023Q2 bcow Treasury Stock Value Issued Cost Method
TreasuryStockValueIssuedCostMethod
6000
CY2023Q2 bcow Adjustments To Additional Paid In Capital Purchase And Retirement Of Common Stock
AdjustmentsToAdditionalPaidInCapitalPurchaseAndRetirementOfCommonStock
-43000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
149000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
74126000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
90893000
us-gaap Net Income Loss
NetIncomeLoss
-296000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-8712000
bcow Reimbursement Of Stock Offering Costs
ReimbursementOfStockOfferingCosts
-1000
us-gaap Employee Stock Ownership Plan Esop Shares Contributed To Esop
EmployeeStockOwnershipPlanESOPSharesContributedToESOP
96446
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1062000
bcow Employee Stock Ownership Plan Esop Number Of Committed To Be Released Shares During Period
EmployeeStockOwnershipPlanEsopNumberOfCommittedToBeReleasedSharesDuringPeriod
14798
bcow Employee Stock Ownership Plan Value Committed To Be Released
EmployeeStockOwnershipPlanValueCommittedToBeReleased
101000
bcow Adjustments To Additional Paid In Capital Purchase And Retirement Of Common Stock
AdjustmentsToAdditionalPaidInCapitalPurchaseAndRetirementOfCommonStock
-78000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
119000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
80966000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
75362000
us-gaap Net Income Loss
NetIncomeLoss
-869000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
284000
bcow Employee Stock Ownership Plan Esop Number Of Committed To Be Released Shares During Period
EmployeeStockOwnershipPlanEsopNumberOfCommittedToBeReleasedSharesDuringPeriod
9782
bcow Employee Stock Ownership Plan Value Committed To Be Released
EmployeeStockOwnershipPlanValueCommittedToBeReleased
77000
bcow Adjustments To Additional Paid In Capital Repurchase And Cancellation Of Common Stock Stock Repurchase Program Shares
AdjustmentsToAdditionalPaidInCapitalRepurchaseAndCancellationOfCommonStockStockRepurchaseProgramShares
27303
bcow Adjustments To Additional Paid In Capital Repurchase And Cancellation Of Common Stock Stock Repurchase Program Value
AdjustmentsToAdditionalPaidInCapitalRepurchaseAndCancellationOfCommonStockStockRepurchaseProgramValue
-232000
bcow Treasury Stock Value Issued Cost Method
TreasuryStockValueIssuedCostMethod
6000
bcow Adjustments To Additional Paid In Capital Purchase And Retirement Of Common Stock
AdjustmentsToAdditionalPaidInCapitalPurchaseAndRetirementOfCommonStock
-56000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
337000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
74126000
us-gaap Profit Loss
ProfitLoss
-869000
us-gaap Profit Loss
ProfitLoss
-296000
bcow Net Amortization From Investment Securities
NetAmortizationFromInvestmentSecurities
37000
bcow Net Amortization From Investment Securities
NetAmortizationFromInvestmentSecurities
90000
us-gaap Depreciation
Depreciation
252000
us-gaap Depreciation
Depreciation
310000
bcow Provision Credit For Loan Losses
ProvisionCreditForLoanLosses
150000
bcow Provision Credit For Loan Losses
ProvisionCreditForLoanLosses
210000
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
444000
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-733000
bcow Stock Compensation Expense
StockCompensationExpense
337000
bcow Stock Compensation Expense
StockCompensationExpense
119000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-424000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-192000
us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
4043000
us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
13760000
us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
4236000
us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
14865000
us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
68000
us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
184000
us-gaap Share Based Compensation
ShareBasedCompensation
77000
us-gaap Share Based Compensation
ShareBasedCompensation
101000
us-gaap Increase Decrease In Insurance Settlements Receivable
IncreaseDecreaseInInsuranceSettlementsReceivable
217000
us-gaap Increase Decrease In Insurance Settlements Receivable
IncreaseDecreaseInInsuranceSettlementsReceivable
209000
bcow Increase Decrease In Mortgage Servicing Rights
IncreaseDecreaseInMortgageServicingRights
-83000
bcow Increase Decrease In Mortgage Servicing Rights
IncreaseDecreaseInMortgageServicingRights
-97000
bcow Increase Decrease In Accrued Interest Receivable And Other Assets
IncreaseDecreaseInAccruedInterestReceivableAndOtherAssets
135000
bcow Increase Decrease In Accrued Interest Receivable And Other Assets
IncreaseDecreaseInAccruedInterestReceivableAndOtherAssets
753000
bcow Increase Decrease In Accrued Interest Payable And Other Liabilities
IncreaseDecreaseInAccruedInterestPayableAndOtherLiabilities
192000
bcow Increase Decrease In Accrued Interest Payable And Other Liabilities
IncreaseDecreaseInAccruedInterestPayableAndOtherLiabilities
-520000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-836000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
611000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
7212000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
10879000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
37139000
us-gaap Payments To Acquire Equity Securities Fv Ni
PaymentsToAcquireEquitySecuritiesFvNi
54000
us-gaap Payments To Acquire Equity Securities Fv Ni
PaymentsToAcquireEquitySecuritiesFvNi
56000
us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
21371000
us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
26040000
us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
1441000
us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
720000
us-gaap Proceeds From Sale Of Equity Securities Fv Ni
ProceedsFromSaleOfEquitySecuritiesFvNi
12000
bcow Payments For Proceeds From Acquire Property Plant And Equipment
PaymentsForProceedsFromAcquirePropertyPlantAndEquipment
-108000
bcow Payments For Proceeds From Acquire Property Plant And Equipment
PaymentsForProceedsFromAcquirePropertyPlantAndEquipment
-131000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15030000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-52487000
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-16531000
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-1439000
us-gaap Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance
IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance
7112000
us-gaap Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance
IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance
5879000
us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
99500000
us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
10000000
us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
79476000
us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
8007000
bcow Reimbursement Of Stock Offering Costs
ReimbursementOfStockOfferingCosts
-1000
bcow Repurchase And Cancellation Of Common Stock
RepurchaseAndCancellationOfCommonStock
232000
bcow Purchase And Retirement Of Common Stock
PurchaseAndRetirementOfCommonStock
56000
bcow Purchase And Retirement Of Common Stock
PurchaseAndRetirementOfCommonStock
78000
bcow Payments To Repurchase Shares Under Employee Stock Ownership Plan
PaymentsToRepurchaseSharesUnderEmployeeStockOwnershipPlan
1062000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10317000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5294000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5549000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-46582000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
28344000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
66803000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22795000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
20221000
us-gaap Interest Paid Net
InterestPaidNet
3022000
us-gaap Interest Paid Net
InterestPaidNet
691000
us-gaap Nature Of Operations
NatureOfOperations
<p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTE 1 – NATURE OF OPERATIONS AND BASIS OF PRESENTATION</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1895 Bancorp of Wisconsin, Inc., a Maryland corporation (the “Company” or “New 1895 Bancorp”) was formed to serve as the stock holding company for PyraMax Bank, FSB (the “Bank”) as part of the mutual-to-stock conversion of 1895 Bancorp of Wisconsin, MHC. Upon completion of the conversion, which occurred on July 14, 2021, 1895 Bancorp of Wisconsin, MHC and 1895 Bancorp of Wisconsin, a federal corporation (“Old 1895 Bancorp”), ceased to exist and New 1895 Bancorp became the successor corporation to Old 1895 Bancorp. The conversion was accomplished by the merger of 1895 Bancorp of Wisconsin, MHC with and into Old 1895 Bancorp followed by the merger of Old 1895 Bancorp with and into New 1895 Bancorp. The shares of New 1895 Bancorp common stock that were offered for sale in connection with the conversion represented the majority ownership interest in Old 1895 Bancorp owned by 1895 Bancorp of Wisconsin, MHC. On July 14, 2021, public stockholders of Old 1895 Bancorp received 1.3163 shares of common stock of New 1895 Bancorp in exchange for each of their shares of Old 1895 Bancorp common stock. The shares of Old 1895 Bancorp common stock owned by 1895 Bancorp of Wisconsin, MHC were canceled at that time. The conversion and offering were completed on July 14, 2021, and New 1895 Bancorp was organized as a fully public stock holding company, with </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">100</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the common stock being held by the public. The consolidated financial statements and other financial information contained in these consolidated financial statements are for New 1895 Bancorp.</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The cost of the reorganization and the issuing of the common stock totaling $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million were deferred and deducted from the sales proceeds of the offering.</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PyraMax Bank is a stock savings bank headquartered in Greenfield, Wisconsin. PyraMax Bank operates as a full-service financial institution, providing a full range of financial services, including the granting of commercial, residential, and consumer loans and acceptance of deposits from individual customers and small businesses in the metropolitan Milwaukee, Wisconsin area. PyraMax Bank is subject to competition from other financial and nonfinancial institutions providing financial products. In addition, PyraMax Bank is subject to the regulations of certain regulatory agencies and undergoes periodic examination by those regulatory agencies.</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying unaudited interim consolidated financial statements and the notes thereto have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”). In the opinion of management, the accompanying unaudited interim consolidated financial statements contain all normal recurring adjustments necessary to present fairly the financial position, results of operations, changes in stockholders' equity and cash flows as of and for the periods presented. Certain amounts from prior periods have been reclassified to conform with current period presentation.</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying unaudited consolidated financial statements and related notes should be read in conjunction with the audited annual consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the Securities and Exchange Commission on March 30, 2023.</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In preparing financial statements in conformity with GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the balance sheet, and reported amounts of revenues and expenses during the reporting period. Material estimates that are particularly susceptible to significant change in the near term relate to the determination of the allowance for credit losses, the fair value of investment securities, financial instruments and mortgage servicing rights, and the valuation of deferred income tax assets. Actual results could differ from those estimates.</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On April 5, 2012, the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Jumpstart Our Business Startups Act</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (the “JOBS Act”) was signed into law. The JOBS Act contains provisions that, among other things, reduce certain reporting requirements for qualifying public companies and define an “emerging growth company.” As an emerging growth company, the Company may delay adoption of new or revised financial accounting standards until such date that the standards are required to be adopted by non-issuer companies. If such standards would not apply to non-issuer companies, no deferral would be applicable. The Company intends to take advantage of the benefits of the extended transition periods allowed under the JOBS Act.</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accordingly, the Company’s financial statements may not be comparable to those of public companies that adopt new or revised financial accounting standards as of an earlier date. The effective dates of the recent accounting standards in Note 2 reflect those that relate to non-issuer companies.</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTE 1 – NATURE OF OPERATIONS AND BASIS OF PRESENTATION (continued)</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Subsequent Events</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Management has reviewed the Company's operations for potential disclosure or financial statement impacts related to events occurring after June 30, 2023, but prior to the release of the unaudited consolidated financial statements contained in this quarterly report on Form 10-Q were issued.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There were no additional subsequent event disclosures or financial statement impacts related to events occurring after June 30, 2023</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> that warranted adjustment to or disclosure in these unaudited consolidated financial statements.</span></p>
CY2023Q2 bcow Common Stock Held By Public
CommonStockHeldByPublic
1
bcow Reorganization Cost And Issuing Of Common Stock Deferred
ReorganizationCostAndIssuingOfCommonStockDeferred
2000000
CY2023Q2 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
122984000
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2000
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
15355000
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
107631000
CY2022Q4 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
130233000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
6000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
15747000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
114492000
CY2023Q2 us-gaap Deposit Liabilities Collateral Issued Financial Instruments
DepositLiabilitiesCollateralIssuedFinancialInstruments
8900000
CY2022Q4 us-gaap Deposit Liabilities Collateral Issued Financial Instruments
DepositLiabilitiesCollateralIssuedFinancialInstruments
3600000
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
1080000
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1058000
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
29133000
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
26429000
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
17170000
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
14312000
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
3114000
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
2425000
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
50497000
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
44224000
CY2023Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
122984000
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
107631000
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
6025000
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
354000
CY2023Q2 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
101264000
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
15001000
CY2023Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
107289000
CY2023Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
15355000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
30114000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
1786000
CY2022Q4 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
83955000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
13961000
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
114069000
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
15747000
CY2023Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
85
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
92
us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Other Default Rate
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureOtherDefaultRate
0.125
CY2022 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Other Default Rate
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureOtherDefaultRate
0.121
CY2023Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
383278000
CY2022Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
361947000
CY2023Q2 us-gaap Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums
UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums
881000
CY2022Q4 us-gaap Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums
UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums
830000
CY2023Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
3643000
CY2022Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
3203000
CY2023Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
380516000
CY2022Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
359574000
CY2023Q2 bcow Loans And Leases Receivable Interest Receivable
LoansAndLeasesReceivableInterestReceivable
944000
CY2022Q4 bcow Loans And Leases Receivable Interest Receivable
LoansAndLeasesReceivableInterestReceivable
874000
CY2023Q2 us-gaap Deposit Liabilities Reclassified As Loans Receivable1
DepositLiabilitiesReclassifiedAsLoansReceivable1
17000
CY2022Q4 us-gaap Deposit Liabilities Reclassified As Loans Receivable1
DepositLiabilitiesReclassifiedAsLoansReceivable1
98000
CY2023Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
3693000
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
1000
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
9000
CY2023Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
3643000
CY2023Q2 bcow Allowance For Credit Losses For Loans And Unfunded Loan Commitments Amount
AllowanceForCreditLossesForLoansAndUnfundedLoanCommitmentsAmount
4441000
CY2022Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
3017000
CY2022Q2 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
105000
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
1000
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
11000
CY2022Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
3132000
CY2022Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
3203000
bcow Cecl Adoption Adjustment
CeclAdoptionAdjustment
412000
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
7000
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
18000
CY2023Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
3643000
CY2023Q2 bcow Allowance For Credit Losses For Loans And Unfunded Loan Commitments Amount
AllowanceForCreditLossesForLoansAndUnfundedLoanCommitmentsAmount
4441000
CY2021Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
2858000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
210000
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
4000
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
68000
CY2022Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
3132000
CY2023Q2 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
75000
CY2022Q2 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
105000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
150000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
210000
CY2023Q2 us-gaap Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
30313000
CY2023Q2 us-gaap Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
99168000
CY2023Q2 us-gaap Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
94970000
CY2023Q2 us-gaap Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
59798000
CY2023Q2 us-gaap Financing Receivable Originated Four Years Before Latest Fiscal Year
FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear
14502000
CY2023Q2 us-gaap Financing Receivable Originated Five Or More Years Before Latest Fiscal Year
FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
59448000
CY2023Q2 us-gaap Financing Receivable Revolving
FinancingReceivableRevolving
24174000
CY2023Q2 us-gaap Financing Receivable Revolving Converted To Term Loan
FinancingReceivableRevolvingConvertedToTermLoan
905000
CY2023Q2 us-gaap Financing Receivable Before Allowance For Credit Loss And Fee
FinancingReceivableBeforeAllowanceForCreditLossAndFee
383278000
CY2023Q2 us-gaap Notes Receivable Gross
NotesReceivableGross
383218000
CY2023Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
383278000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
359876000
CY2022Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
361947000
CY2023Q2 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
0
CY2022Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
0
CY2023Q2 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
714000
CY2022Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
769000
CY2023Q2 us-gaap Loans And Leases Receivable Ratio Of Nonperforming Loans To All Loans
LoansAndLeasesReceivableRatioOfNonperformingLoansToAllLoans
0.0019
CY2022Q4 us-gaap Loans And Leases Receivable Ratio Of Nonperforming Loans To All Loans
LoansAndLeasesReceivableRatioOfNonperformingLoansToAllLoans
0.0021
CY2023Q2 bcow Loans And Leases Receivable Ratio Of Nonperforming Loans To All Assets
LoansAndLeasesReceivableRatioOfNonperformingLoansToAllAssets
0.0013
CY2022Q4 bcow Loans And Leases Receivable Ratio Of Nonperforming Loans To All Assets
LoansAndLeasesReceivableRatioOfNonperformingLoansToAllAssets
0.0014
CY2023Q2 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
714000
us-gaap Financing Receivable Nonaccrual Interest Income
FinancingReceivableNonaccrualInterestIncome
0
CY2023Q1 bcow Collateral Dependent Loans
CollateralDependentLoans
4931000
CY2022Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
4497000
CY2022Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
357450000
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
361947000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
3203000
CY2022Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
3203000
CY2022Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
4497000
CY2022Q4 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
4771000
CY2022 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
6325000
CY2022 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
344000
CY2022Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
4497000
CY2022Q4 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
4771000
CY2022Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
0
CY2022 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
6325000
CY2022 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
344000
CY2022Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
538000
CY2022Q4 bcow Financing Receivable Modifications Recorded Investment Nonaccrual Amount
FinancingReceivableModificationsRecordedInvestmentNonaccrualAmount
183000
CY2022 us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
0
CY2023Q2 bcow Unpaid Principal Balance Of Loans Serviced For Others
UnpaidPrincipalBalanceOfLoansServicedForOthers
291500000
CY2022Q4 bcow Unpaid Principal Balance Of Loans Serviced For Others
UnpaidPrincipalBalanceOfLoansServicedForOthers
304300000
CY2023Q1 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
1824000
CY2022Q1 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
1988000
CY2022Q4 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
1860000
CY2021Q4 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
2036000
CY2023Q2 us-gaap Servicing Asset At Amortized Value Additions
ServicingAssetAtAmortizedValueAdditions
8000
CY2022Q2 us-gaap Servicing Asset At Amortized Value Additions
ServicingAssetAtAmortizedValueAdditions
20000
us-gaap Servicing Asset At Amortized Value Additions
ServicingAssetAtAmortizedValueAdditions
17000
us-gaap Servicing Asset At Amortized Value Additions
ServicingAssetAtAmortizedValueAdditions
47000
CY2023Q2 us-gaap Servicing Asset At Amortized Value Amortization1
ServicingAssetAtAmortizedValueAmortization1
55000
CY2022Q2 us-gaap Servicing Asset At Amortized Value Amortization1
ServicingAssetAtAmortizedValueAmortization1
69000
us-gaap Servicing Asset At Amortized Value Amortization1
ServicingAssetAtAmortizedValueAmortization1
100000
us-gaap Servicing Asset At Amortized Value Amortization1
ServicingAssetAtAmortizedValueAmortization1
144000
CY2023Q2 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
1777000
CY2022Q2 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
1939000
CY2023Q2 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
1777000
CY2022Q2 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
1939000
CY2023Q1 us-gaap Servicing Asset At Amortized Value Fair Value
ServicingAssetAtAmortizedValueFairValue
3488000
CY2022Q1 us-gaap Servicing Asset At Amortized Value Fair Value
ServicingAssetAtAmortizedValueFairValue
2811000
CY2022Q4 us-gaap Servicing Asset At Amortized Value Fair Value
ServicingAssetAtAmortizedValueFairValue
3376000
CY2021Q4 us-gaap Servicing Asset At Amortized Value Fair Value
ServicingAssetAtAmortizedValueFairValue
2477000
CY2023Q2 us-gaap Servicing Asset At Amortized Value Fair Value
ServicingAssetAtAmortizedValueFairValue
3317000
CY2022Q2 us-gaap Servicing Asset At Amortized Value Fair Value
ServicingAssetAtAmortizedValueFairValue
3273000
CY2023Q2 us-gaap Servicing Asset At Amortized Value Fair Value
ServicingAssetAtAmortizedValueFairValue
3317000
CY2022Q2 us-gaap Servicing Asset At Amortized Value Fair Value
ServicingAssetAtAmortizedValueFairValue
3273000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
89000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
203000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
187000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
167000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
148000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
983000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1777000
CY2023Q2 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
74825000
CY2022Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
92465000
CY2023Q2 us-gaap Interest Bearing Domestic Deposit Demand
InterestBearingDomesticDepositDemand
30002000
CY2022Q4 us-gaap Interest Bearing Domestic Deposit Demand
InterestBearingDomesticDepositDemand
32514000
CY2023Q2 us-gaap Interest Bearing Domestic Deposit Money Market
InterestBearingDomesticDepositMoneyMarket
96673000
CY2022Q4 us-gaap Interest Bearing Domestic Deposit Money Market
InterestBearingDomesticDepositMoneyMarket
121215000
CY2023Q2 us-gaap Interest Bearing Domestic Deposit Savings
InterestBearingDomesticDepositSavings
50785000
CY2022Q4 us-gaap Interest Bearing Domestic Deposit Savings
InterestBearingDomesticDepositSavings
61969000
CY2023Q2 us-gaap Interest Bearing Domestic Deposit Certificates Of Deposits
InterestBearingDomesticDepositCertificatesOfDeposits
118905000
CY2022Q4 us-gaap Interest Bearing Domestic Deposit Certificates Of Deposits
InterestBearingDomesticDepositCertificatesOfDeposits
79558000
CY2023Q2 us-gaap Deposits
Deposits
371190000
CY2022Q4 us-gaap Deposits
Deposits
387721000
CY2023Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2022Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2023Q2 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
22200000
CY2022Q4 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
8900000
CY2023Q2 us-gaap Interest Bearing Domestic Deposit Brokered
InterestBearingDomesticDepositBrokered
0
CY2022Q4 us-gaap Interest Bearing Domestic Deposit Brokered
InterestBearingDomesticDepositBrokered
0
CY2023Q2 us-gaap Time Deposit Maturities Year One
TimeDepositMaturitiesYearOne
40361000
CY2023Q2 us-gaap Time Deposit Maturities Year Two
TimeDepositMaturitiesYearTwo
57372000
CY2023Q2 us-gaap Time Deposit Maturities Year Three
TimeDepositMaturitiesYearThree
8844000
CY2023Q2 us-gaap Time Deposit Maturities Year Four
TimeDepositMaturitiesYearFour
11967000
CY2023Q2 us-gaap Time Deposit Maturities Year Five
TimeDepositMaturitiesYearFive
302000
CY2023Q2 us-gaap Time Deposit Maturities After Year Five
TimeDepositMaturitiesAfterYearFive
59000
CY2023Q2 us-gaap Time Deposits
TimeDeposits
118905000
CY2023Q2 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
91488000
CY2022Q4 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
71464000
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
8900000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
8300000
CY2019Q1 bcow Employee Stock Ownership Plan Esop Shares Adjusted For The Conversion
EmployeeStockOwnershipPlanEsopSharesAdjustedForTheConversion
231047
CY2021Q3 bcow Number Of Shares To Be Contributed To The Employee Stock Ownership Plan
NumberOfSharesToBeContributedToTheEmployeeStockOwnershipPlan
283360
CY2023Q2 us-gaap Federal Home Loan Bank Advances Weighted Average Interest Rate Maturing In Next Twelve Rolling Months
FederalHomeLoanBankAdvancesWeightedAverageInterestRateMaturingInNextTwelveRollingMonths
0.0461
CY2023Q2 us-gaap Federal Home Loan Bank Advances Maturities Summary Due Within One Year Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueWithinOneYearOfBalanceSheetDate
5981000
CY2023Q2 us-gaap Federal Home Loan Bank Advances Weighted Average Interest Rate Maturing In Rolling Year Two
FederalHomeLoanBankAdvancesWeightedAverageInterestRateMaturingInRollingYearTwo
0.0415
CY2023Q2 us-gaap Federal Home Loan Bank Advances Maturities Summary Due From One To Two Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueFromOneToTwoYearsOfBalanceSheetDate
6979000
CY2023Q2 us-gaap Federal Home Loan Bank Advances Weighted Average Interest Rate Maturing In Rolling Year Three
FederalHomeLoanBankAdvancesWeightedAverageInterestRateMaturingInRollingYearThree
0.0112
CY2023Q2 us-gaap Federal Home Loan Bank Advances Maturities Summary Due From Two To Three Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueFromTwoToThreeYearsOfBalanceSheetDate
2002000
CY2023Q2 us-gaap Federal Home Loan Bank Advances Weighted Average Interest Rate Maturing In Rolling Year Four
FederalHomeLoanBankAdvancesWeightedAverageInterestRateMaturingInRollingYearFour
0.0267
CY2023Q2 us-gaap Federal Home Loan Bank Advances Maturities Summary Due From Three To Four Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueFromThreeToFourYearsOfBalanceSheetDate
4524000
CY2023Q2 us-gaap Federal Home Loan Bank Advances Weighted Average Interest Rate Maturing In Rolling Year Five
FederalHomeLoanBankAdvancesWeightedAverageInterestRateMaturingInRollingYearFive
0.0238
CY2023Q2 us-gaap Federal Home Loan Bank Advances Maturities Summary Due From Four To Five Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueFromFourToFiveYearsOfBalanceSheetDate
7047000
CY2023Q2 us-gaap Federal Home Loan Bank Advances Weighted Average Interest Rate Maturing After Rolling Year Five
FederalHomeLoanBankAdvancesWeightedAverageInterestRateMaturingAfterRollingYearFive
0.0258
CY2023Q2 us-gaap Federal Home Loan Bank Advances Maturities Summary Due After Five Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueAfterFiveYearsOfBalanceSheetDate
64955000
CY2023Q2 us-gaap Federal Home Loan Bank Advances Weighted Average Interest Rate
FederalHomeLoanBankAdvancesWeightedAverageInterestRate
0.0279
CY2023Q2 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
91488000
bcow Description Of Maximum Borrowing Capacity
DescriptionOfMaximumBorrowingCapacity
The Company maintains a master contract agreement with the FHLB, which provides for borrowing up to the lesser of 22.22 times the value of the FHLB stock owned, a determined percentage of the book value of the Company’s qualifying real estate loans, or a determined percentage of the Company’s assets.
CY2023Q2 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
4900000
CY2022Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
3400000
CY2023Q2 us-gaap Federal Home Loan Bank Advances General Debt Obligations Disclosures Amount Of Available Unused Funds
FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresAmountOfAvailableUnusedFunds
73200000
CY2022Q4 us-gaap Federal Home Loan Bank Advances General Debt Obligations Disclosures Amount Of Available Unused Funds
FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresAmountOfAvailableUnusedFunds
100000000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-273000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-133000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-424000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-192000
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
934000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
934000
CY2022Q2 bcow Number Of Additional Shares Contributed To Employee Stock Ownership Plan
NumberOfAdditionalSharesContributedToEmployeeStockOwnershipPlan
283360
CY2022Q2 bcow Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Additional Shares Purchased
EmployeeStockOwnershipPlanEsopWeightedAveragePurchasePriceOfAdditionalSharesPurchased
10.9
CY2023Q2 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
30000
CY2022Q2 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
51000
us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
77000
us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
101000
CY2023Q2 bcow Shares Committed To Be Released
SharesCommittedToBeReleased
9782
CY2022Q4 bcow Shares Committed To Be Released
SharesCommittedToBeReleased
19730
CY2023Q2 us-gaap Employee Stock Ownership Plan Esop Number Of Allocated Shares
EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares
55900
CY2022Q4 us-gaap Employee Stock Ownership Plan Esop Number Of Allocated Shares
EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares
36170
CY2023Q2 bcow Employee Stock Ownership Plan Esop Number Of Unallocated Shares
EmployeeStockOwnershipPlanEsopNumberOfUnallocatedShares
444010
CY2022Q4 bcow Employee Stock Ownership Plan Esop Number Of Unallocated Shares
EmployeeStockOwnershipPlanEsopNumberOfUnallocatedShares
453792
CY2023Q2 us-gaap Employee Stock Ownership Plan Esop Shares In Esop
EmployeeStockOwnershipPlanESOPSharesInESOP
509692
CY2022Q4 us-gaap Employee Stock Ownership Plan Esop Shares In Esop
EmployeeStockOwnershipPlanESOPSharesInESOP
509692
CY2023Q2 bcow Common Stock Shares Conversion Ratio As Part Of Offering Pursuant To Share Based Scheme
CommonStockSharesConversionRatioAsPartOfOfferingPursuantToShareBasedScheme
7.51
CY2022Q4 bcow Common Stock Shares Conversion Ratio As Part Of Offering Pursuant To Share Based Scheme
CommonStockSharesConversionRatioAsPartOfOfferingPursuantToShareBasedScheme
10
CY2023Q2 us-gaap Employee Stock Ownership Plan Esop Deferred Shares Fair Value
EmployeeStockOwnershipPlanESOPDeferredSharesFairValue
3335000
CY2022Q4 us-gaap Employee Stock Ownership Plan Esop Deferred Shares Fair Value
EmployeeStockOwnershipPlanESOPDeferredSharesFairValue
4538000
CY2022Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
1015000
CY2021Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
932000
us-gaap Loans And Leases Receivable Related Parties Period Increase Decrease
LoansAndLeasesReceivableRelatedPartiesPeriodIncreaseDecrease
0
CY2022 us-gaap Loans And Leases Receivable Related Parties Period Increase Decrease
LoansAndLeasesReceivableRelatedPartiesPeriodIncreaseDecrease
0
us-gaap Loans And Leases Receivable Related Parties Additions
LoansAndLeasesReceivableRelatedPartiesAdditions
218000
CY2022 us-gaap Loans And Leases Receivable Related Parties Additions
LoansAndLeasesReceivableRelatedPartiesAdditions
169000
us-gaap Loans And Leases Receivable Related Parties Proceeds
LoansAndLeasesReceivableRelatedPartiesProceeds
37000
CY2022 us-gaap Loans And Leases Receivable Related Parties Proceeds
LoansAndLeasesReceivableRelatedPartiesProceeds
86000
CY2023Q2 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
1196000
CY2022Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
1015000
CY2023Q2 us-gaap Marketable Securities
MarketableSecurities
3416000
CY2023Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
111047000
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
2924000
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
117416000
CY2023Q2 bcow Impairment Loan On Mortgage Servicing Rights
ImpairmentLoanOnMortgageServicingRights
0
CY2022Q4 bcow Impairment Loan On Mortgage Servicing Rights
ImpairmentLoanOnMortgageServicingRights
0
CY2023Q2 bcow Impairment Loan On Mortgage Servicing Rights
ImpairmentLoanOnMortgageServicingRights
0
CY2022Q4 bcow Impairment Loan On Mortgage Servicing Rights
ImpairmentLoanOnMortgageServicingRights
0
CY2023Q2 bcow Consolidated Asset Threshold For Small Bank Holding Companies Maximum
ConsolidatedAssetThresholdForSmallBankHoldingCompaniesMaximum
3000000000
CY2023Q2 us-gaap Common Equity Tier One Capital
CommonEquityTierOneCapital
64508000
CY2023Q2 us-gaap Common Equity Tier One Capital Ratio
CommonEquityTierOneCapitalRatio
0.117
CY2023Q2 bcow Common Equity Tier One Risk Based Capital Required For Capital Adequacy
CommonEquityTierOneRiskBasedCapitalRequiredForCapitalAdequacy
22010000
CY2023Q2 bcow Common Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets
CommonTierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.04
CY2023Q2 us-gaap Common Equity Tier One Capital Required To Be Well Capitalized
CommonEquityTierOneCapitalRequiredToBeWellCapitalized
27513000
CY2023Q2 bcow Common Equity Tier One Capital Required To Be Well Capitalized To Risk Weighted Assets
CommonEquityTierOneCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.05
CY2023Q2 us-gaap Capital
Capital
64508000
CY2023Q2 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
0.157
CY2023Q2 us-gaap Capital Required For Capital Adequacy
CapitalRequiredForCapitalAdequacy
18515000
CY2023Q2 us-gaap Capital Required For Capital Adequacy To Risk Weighted Assets
CapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.045
CY2023Q2 us-gaap Capital Required To Be Well Capitalized
CapitalRequiredToBeWellCapitalized
26744000
CY2023Q2 us-gaap Capital Required To Be Well Capitalized To Risk Weighted Assets
CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.065
CY2023Q2 us-gaap Tier One Risk Based Capital
TierOneRiskBasedCapital
64508000
CY2023Q2 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
0.157
CY2023Q2 us-gaap Tier One Risk Based Capital Required For Capital Adequacy
TierOneRiskBasedCapitalRequiredForCapitalAdequacy
24687000
CY2023Q2 us-gaap Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.06
CY2023Q2 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized
TierOneRiskBasedCapitalRequiredToBeWellCapitalized
32916000
CY2023Q2 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.08
CY2023Q2 us-gaap Tier One Leverage Capital
TierOneLeverageCapital
68949000
CY2023Q2 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
0.168
CY2023Q2 us-gaap Tier One Leverage Capital Required For Capital Adequacy
TierOneLeverageCapitalRequiredForCapitalAdequacy
32916000
CY2023Q2 us-gaap Tier One Leverage Capital Required For Capital Adequacy To Average Assets
TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets
0.08
CY2023Q2 us-gaap Tier One Leverage Capital Required To Be Well Capitalized
TierOneLeverageCapitalRequiredToBeWellCapitalized
41145000
CY2023Q2 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
0.10
CY2022Q4 us-gaap Common Equity Tier One Capital
CommonEquityTierOneCapital
65497000
CY2022Q4 us-gaap Common Equity Tier One Capital Ratio
CommonEquityTierOneCapitalRatio
0.119
CY2022Q4 bcow Common Equity Tier One Risk Based Capital Required For Capital Adequacy
CommonEquityTierOneRiskBasedCapitalRequiredForCapitalAdequacy
22086000
CY2022Q4 bcow Common Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets
CommonTierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.04
CY2022Q4 us-gaap Common Equity Tier One Capital Required To Be Well Capitalized
CommonEquityTierOneCapitalRequiredToBeWellCapitalized
27608000
CY2022Q4 bcow Common Equity Tier One Capital Required To Be Well Capitalized To Risk Weighted Assets
CommonEquityTierOneCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.05
CY2022Q4 us-gaap Capital
Capital
65497000
CY2022Q4 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
0.166
CY2022Q4 us-gaap Capital Required For Capital Adequacy
CapitalRequiredForCapitalAdequacy
17711000
CY2022Q4 us-gaap Capital Required For Capital Adequacy To Risk Weighted Assets
CapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.045
CY2022Q4 us-gaap Capital Required To Be Well Capitalized
CapitalRequiredToBeWellCapitalized
25583000
CY2022Q4 us-gaap Capital Required To Be Well Capitalized To Risk Weighted Assets
CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.065
CY2022Q4 us-gaap Tier One Risk Based Capital
TierOneRiskBasedCapital
65497000
CY2022Q4 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
0.166
CY2022Q4 us-gaap Tier One Risk Based Capital Required For Capital Adequacy
TierOneRiskBasedCapitalRequiredForCapitalAdequacy
23615000
CY2022Q4 us-gaap Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.06
CY2022Q4 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized
TierOneRiskBasedCapitalRequiredToBeWellCapitalized
31486000
CY2022Q4 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.08
CY2022Q4 us-gaap Tier One Leverage Capital
TierOneLeverageCapital
68700000
CY2022Q4 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
0.175
CY2022Q4 us-gaap Tier One Leverage Capital Required For Capital Adequacy
TierOneLeverageCapitalRequiredForCapitalAdequacy
31486000
CY2022Q4 us-gaap Tier One Leverage Capital Required For Capital Adequacy To Average Assets
TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets
0.08
CY2022Q4 us-gaap Tier One Leverage Capital Required To Be Well Capitalized
TierOneLeverageCapitalRequiredToBeWellCapitalized
39358000
CY2022Q4 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
0.10
CY2022Q3 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
319766
CY2022Q3 bcow Percentage Of Repurchase Of Outstanding Shares
PercentageOfRepurchaseOfOutstandingShares
0.05
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
319766
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
3400000
CY2023Q2 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
621522
CY2023Q2 bcow Percentage Of Repurchase Of Outstanding Shares
PercentageOfRepurchaseOfOutstandingShares
0.10
CY2023Q2 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
4455
CY2023Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
34000
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
130155
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11314
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
169167
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
179938
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-508000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-241000
CY2023Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
5991777000
CY2022Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
6289572000
CY2023Q2 us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
446442000
CY2022Q2 us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
446468000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5545335
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5843104
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5545335
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5843104
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Net Income Loss
NetIncomeLoss
-869000
us-gaap Net Income Loss
NetIncomeLoss
-296000
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
5997436000
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
6282749000
us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
448874000
us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
424300000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5548562
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5858449
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5548562
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5858449
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0359
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0306
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.2464
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.2464
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y6M
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y6M
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
3.37
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
3.25
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
656130
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.27
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y8M8D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1122214000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
9.94
bcow Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term1
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm1
P6Y6M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
43489
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
8.7
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
615641
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.24
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y7D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
379761000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
174786
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.21
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y4M13D
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
237372000
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
543306
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
2.82
bcow Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedgrantednumberofshares
Sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedgrantednumberofshares
3000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.37
bcow Sharebased Compensation Arrangement By Share Based Payment Award Options Nonvested Vested Number Of Shares
SharebasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedVestedNumberOfShares
-61962
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
1.67
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
43489
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
8.7
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
440855
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
2.99
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1100000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P4Y
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
211349
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
8.71
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
24606
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
6.43
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
13910
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
8.86
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
172833
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
9.02
bcow Sharebased Compensation Arrangement Equity Instruments Other Than Options Vested Realted To Shares Surrenders To Cover Payroll Taxes In Period
SharebasedCompensationArrangementEquityInstrumentsOtherThanOptionsVestedRealtedToSharesSurrendersToCoverPayrollTaxesInPeriod
7368

Files In Submission

Name View Source Status
0000950170-23-041457-index-headers.html Edgar Link pending
0000950170-23-041457-index.html Edgar Link pending
0000950170-23-041457.txt Edgar Link pending
0000950170-23-041457-xbrl.zip Edgar Link pending
bcow-20230630.htm Edgar Link pending
bcow-20230630.xsd Edgar Link pending
bcow-ex31_1.htm Edgar Link pending
bcow-ex31_2.htm Edgar Link pending
bcow-ex32_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
bcow-20230630_cal.xml Edgar Link unprocessable
bcow-20230630_lab.xml Edgar Link unprocessable
bcow-20230630_def.xml Edgar Link unprocessable
bcow-20230630_pre.xml Edgar Link unprocessable
bcow-20230630_htm.xml Edgar Link completed
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable